CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale CHIEF MEDICAL OFFICER sold 58,424 shares at an average $53.71 ($3,137,823)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 4 Planned sale CHAIRMAN & CEO sold 48,565 shares at $54.02 ($2,623,481)
- 4 Planned sale CHAIRMAN & CEO sold 508,339 shares at an average $51.96 ($26,415,228)
- 4 Planned sale Director sold 13,099 shares at $50.10 ($656,260)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 6,625 shares at $46.69 ($309,321)
- 4 Planned sale CHIEF OPERATING OFFICER sold 1,703 shares at $46.69 ($79,513)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes CHIEF STRATEGY OFFICER gave up 846 shares (to pay taxes)
Page 3 of 39 · 777 filings